Skip to main content
Clinical Trials/NCT02030470
NCT02030470
Completed
Phase 4

Evaluation of Photodynamic Treatment FOTOSAN® Efficacy in Periodontology

University Hospital, Strasbourg, France1 site in 1 country36 target enrollmentJune 1, 2014
ConditionsPeriodontitis

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Periodontitis
Sponsor
University Hospital, Strasbourg, France
Enrollment
36
Locations
1
Primary Endpoint
Change of periodontal pocket depth
Status
Completed
Last Updated
3 months ago

Overview

Brief Summary

Periodontitis are infectious and inflammatory diseases of gum and tooth supporting tissues leading to tooth loss and oral disability. Twenty to 30 percents of patients treated for periodontal diseases display more or less pronounced persistence of periodontal tissue infection, inflammation, and destruction. The therapeutic additional value of photodynamic anti-infectious treatment remains controversial. The objective of this study is to evaluate the mid-term effect of the photodynamic device Fotosan®630 on severe periodontitis treatment outcomes and to define its specific therapeutic indications.

Registry
clinicaltrials.gov
Start Date
June 1, 2014
End Date
March 1, 2018
Last Updated
3 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • aged 40 years
  • signed informed consent
  • generalized severe chronic periodontitis
  • patient with at least 24 teeth
  • more than 30% of sites with clinical attachment loss \>5mm- at least 5 sites with pocket depth \>4mm per quadrant- at least one molar per quadrant- evidenced bone loss on radiographs- bleeding on probing ≥30%

Exclusion Criteria

  • aggressive periodontitis
  • smoking more than 10cig/day
  • patient with endocarditis risk or need of antibiotic prophylaxis
  • pregnant women
  • patient included in other trials
  • patient under guardianship
  • patient treated with antibiotics, anti-inflammatory, and other drugs (inhibitors of calcium channels…) influencing periodontal status within 6 months before examination
  • patient suffering from diseases influencing periodontal status (diabetes…)
  • patient periodontally treated with root planing or periodontal surgery within 1 year before examination
  • patient with scheduled extensive prosthetic treatment

Outcomes

Primary Outcomes

Change of periodontal pocket depth

Time Frame: 6 months

Study period for each participant : 6 months Inclusion period: 24 monthTotal study duration: 30 month

Secondary Outcomes

  • Change of periodontal clinical attachment level, gingival inflammation and dental plaque indexChange of periodontal microflora(6 months)

Study Sites (1)

Loading locations...

Similar Trials